EVONIK INDUSTRIES AGEE

EVONIK INDUSTRIES AG

19.05EURD
−0.97−4.85%
At close at 05:51 GMT
EUR
No trades
See on Supercharts

EVK fundamentals

Key facts

Market capitalization‪9.33 B‬EUR
Founded2006
Employees (FY)‪31.93 K‬
CEOChristian Kullmann
Websiteevonik.de
About

Evonik Industries AG operates as a holding company, which manufactures specialty chemical products. It operates through the following segments: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives segment includes powerful additives and versatile crosslinkers. The Nutrition & Care segment provides products for human well-being and the quality of life. The Smart Materials segment includes businesses with innovative materials that enable resource-saving solutions and replace conventional materials. The Performance Materials segment brings together businesses with the same DNA and it focuses on resource-saving production, new applications and specialties. The Technology & Infrastructure segment provides services which are required across the asset lifecycle of chemical production plants. The company was founded in 1919 and is headquartered in Essen, Germany.

Ownership
‪‪466.00 M‬‬
Closely held shares
‪‪237.66 M‬‬ (51%)
Free Float shares
‪‪228.34 M‬‬ (49%)
Closely held shares
‪‪237.66 M‬‬ (51%)
Free Float shares
‪‪228.34 M‬‬ (49%)
Capital structure
Market cap
‪‪9.33 B‬‬
Debt
‪‪4.57 B‬‬
Minority interest
‪‪82.00 M‬‬
Cash & equivalents
‪‪733.00 M‬‬
Enterprise value
‪‪13.25 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪9.33 B‬‬
Price to earning ratio (P/E)
31.20x
Price to sales ratio (P/S)
0.62x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
31.20x
Price to sales ratio (P/S)
0.62x
Valuation ratios
‪0.00‬
‪0.17‬
‪0.34‬
‪0.51‬
‪0.68‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪11.00‬
‪22.00‬
‪33.00‬
‪44.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−7.0%‬
‪−3.5%‬
‪0.0%‬
‪3.5%‬
‪7.0%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−1.50 B‬‬
‪0.00‬
‪‪1.50 B‬‬
‪‪3.00 B‬‬
‪‪4.50 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪1.00 B‬‬
‪‪2.00 B‬‬
‪‪3.00 B‬‬
‪‪4.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪1.00 B‬‬
‪‪2.00 B‬‬
‪‪3.00 B‬‬
‪‪4.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Smart Materials
Nutrition & Care
Specialty Additives
Technology & Infrastructure
Enabling, Functions, Other Activities, Consolidation
By country
Period: 2024
United States
Germany
Europe Middle East & Africa
Other
Asia-Pacific
China
Switzerland
Netherlands
Brazil
North America

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪0.00‬
‪‪1.00 B‬‬
‪‪2.00 B‬‬
‪‪3.00 B‬‬
‪‪4.00 B‬‬
Actual
Estimate
Earnings
Next:Aug 1, 2025
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪0.00‬
‪0.15‬
‪0.30‬
‪0.45‬
‪0.60‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
182.36%
Payout ratio (TTM)
Dividend yield TTM
5.84%
Last payment
1.17
Last ex-date
May 29, 2025
Last pay date
Jun 3, 2025
Dividend history
‪4.0%‬
‪4.8%‬
‪5.6%‬
‪6.4%‬
‪7.2%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.30‬
‪0.60‬
‪0.90‬
‪1.20‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪1.20 B‬‬
‪‪2.40 B‬‬
‪‪3.60 B‬‬
‪‪4.80 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪4.00 B‬‬
‪‪8.00 B‬‬
‪‪12.00 B‬‬
‪‪16.00 B‬‬
Assets
Liabilities